Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

Nov-14

Pharmacoepidemiology

AUTHORS : Dr Gunnar Brobert, Epidemiology, Bayer AG, 13353 Berlin – Email: gunnar.brobert@bayer.com

JOURNAL : Value in Health

REFERENCE: 17(7):A473-A474

DOI : 10.1016/j.jval.2014.08.1350

Read more

More publications

Dec-25

The effectiveness of bisphosphonates vs denosumab in people with dementia or frailty post hip fracture: a multi-database cohort study

Pharmacoepidemiology

Read more

Sep-25

Real-World Utilization Patterns and Adherence to Subcutaneous and Oral Semaglutide in Adults with Type 2 Diabetes Treated in UK Primary Care

Diabetes Pharmacoepidemiology

Read more

Sep-25

Effect of Orlistat on Bodyweight Among Adults With Overweight or Obesity Without Diabetes: Emulation of a Target Trial Using UK Electronic Medical Records

Pharmacoepidemiology

Read more